Bakertrexate 5 – Methotrexate
Methotrexate 5 mg
Exporter, Distributor Drop shipper to Russia, Brazil, Colombia, Latin America And East Asia
Bakertrexate 5 contains Methotrexate 5 mg, an antimetabolite and immunosuppressive medication used in the treatment of various cancers, autoimmune disorders, and inflammatory conditions. It works by inhibiting DNA synthesis and regulating abnormal immune activity, making it an important therapeutic option in oncology and disease management.
|
Contain |
Methotrexate 5 mg |
|---|---|
|
Strength |
5 mg |
|
Packaging |
10X10TAB |
|
Category |
Categories: Anit Cancer |
|
Manufacturer |
Baker & Davis Private Limited |
|
Brand |
Bakertrexate |
Product Overview
Bakertrexate 5 contains Methotrexate, a well-established antimetabolite medication widely used in oncology, immunology, and rheumatology. It is an essential therapeutic agent indicated for the treatment of certain cancers as well as a variety of autoimmune and inflammatory disorders. Owing to its proven clinical efficacy and extensive therapeutic applications, Methotrexate remains one of the most trusted medicines in modern medical practice.
The medicine works by inhibiting the metabolism of folic acid, which is necessary for DNA synthesis and cellular replication. This action helps slow the growth of rapidly dividing cancer cells while also suppressing abnormal immune system activity associated with autoimmune diseases. As a result, Methotrexate has become an important component of comprehensive treatment protocols across multiple medical specialties.
Bakertrexate 5 is administered under the supervision of qualified healthcare professionals and is widely used in hospitals, specialty clinics, and healthcare institutions worldwide. It may be prescribed as a standalone therapy or incorporated into combination treatment regimens depending on the patient’s medical condition and therapeutic requirements.
How It Works
Methotrexate inhibits the enzyme dihydrofolate reductase (DHFR), reducing the production of folic acid required for DNA synthesis and cell division. This mechanism slows the proliferation of rapidly dividing cells, including cancer cells, while also modulating immune system activity. The dual therapeutic action makes Methotrexate effective in both oncology and autoimmune disease management.
Therapeutic Applications
Bakertrexate 5 may be prescribed as part of treatment protocols for:
- Acute Lymphoblastic Leukemia (ALL)
- Non-Hodgkin’s Lymphoma
- Osteosarcoma
- Breast Cancer
- Psoriasis
- Rheumatoid Arthritis
- Autoimmune Disorders
- Other conditions as determined by the treating physician
The medicine may be used alone or in combination with other therapies based on the patient’s clinical assessment and treatment objectives.
Key Benefits
- Established antimetabolite therapy with proven clinical efficacy.
- Supports treatment of various cancers and autoimmune disorders.
- Helps inhibit abnormal cell growth and immune responses.
- Widely used in oncology and rheumatology treatment protocols.
- Suitable for monotherapy and combination treatment regimens.
- Manufactured under stringent pharmaceutical quality standards.
Quality Commitment
Vinix Biopharma is committed to delivering high-quality pharmaceutical products that meet stringent industry standards. Bakertrexate 5 is manufactured under controlled production environments and undergoes rigorous quality assurance procedures to ensure safety, consistency, and reliability. Every batch is carefully tested to maintain product integrity and support effective patient care.
Storage Information
Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.
Disclaimer
Bakertrexate 5 should be used only under the supervision of a qualified healthcare professional. Dosage and treatment duration should be determined by the treating physician based on the patient’s medical condition, clinical assessment, and approved treatment guidelines.




